Developer docs
API playgroundTry for free, no card

Search company profiles

MicroPort Orthopedics

Full company profile

uuid00028es

Namestring
MicroPort Orthopedics
Legal namestring
MicroPort Orthopedics Inc.
Company typeenum
Private
Founded yearint
1998
Descriptiontext

MicroPort Orthopedics is a privately held medical device company specializing in hip and knee replacement implants and the surgical approaches used to implant them. The company is a subsidiary of MicroPort Scientific Corporation, a China-headquartered multinational medical device group, and operates its principal office in Arlington, Tennessee. It serves orthopedic surgeons, hospitals, and healthcare systems through a direct sales force in core markets and a distributor network that spans 70 countries across North America, Europe, and Asia. The product portfolio is organized around two pillars: knee reconstruction, anchored by the proprietary medial-pivot design introduced in 1998 (Advance) and continued through the Evolution system, including NitrX-coated and BioFoam cementless variants; and hip reconstruction, which includes five acetabular cup platforms (Prime, Dynasty, Lineage, Procotyl, Exclusif), the Profemur femoral stem line, the Conserve Plus resurfacing system, and the Liberty dual-mobility system. Supporting both pillars are tissue-sparing surgical approaches (SuperPath, Anterior Path, SuperCap, PATH) and the SkyWalker FDA-cleared surgical robot.

The company's core technology differentiation is rooted in the medial-pivot knee design, which uses a medial ball-in-socket articulation with lateral mobility to replicate natural knee kinematics, backed by over 1,000,000 implanted cases, 95% reported patient satisfaction, and 98.8% survivorship at 17 years. Material science differentiation comes from BioFoam cancellous titanium for biological fixation, A-Class and E-Class highly cross-linked polyethylene bearing surfaces (with 92% wear reduction versus conventional polyethylene), NitrX titanium niobium nitride coating to reduce metal ion release, and BIOLOXdelta ceramic bearings sourced from CeramTec. The company generates revenue primarily through hardware sales of implants and instruments to hospitals and surgery centers, with pricing negotiated through hospital procurement channels rather than publicly disclosed. Distribution combines direct enterprise field sales in core geographies with channel partner/distributor arrangements internationally. Notable strategic partnerships include a November 2022 US commercialization alliance with Pixee Medical for AR-based surgical navigation integrated with the Evolution knee, an OEM/licensing relationship with CeramTec for ceramic hip heads, distribution agreements with ATF for Liberty and Exclusif hip systems, and a co-development relationship with the Hospital for Special Surgery for the Advance revision knee component.

The company employs 501-1,000 people and raised approximately $81.8M in a May 2020 funding round led by China Life Healthcare Fund. Leadership includes President Benny Hagag, CTO/VP Global Marketing and R&D Paul Bryant, and senior commercial, operations, and applied research officers across its US headquarters and international offices.

Short descriptiontext

MicroPort Orthopedics is a privately held medical device subsidiary of MicroPort Scientific Corporation that designs, manufactures, and distributes hip and knee replacement implants, tissue-sparing surgical approaches, and an FDA-cleared surgical robot, serving orthopedic surgeons and hospitals across 70 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersArlington, United States
HQ citystring
Arlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic medical devices, hip replacement implants, knee replacement systems, joint reconstruction, minimally invasive surgery
Industry3 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
33D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Implants
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Hip and Knee Implant Sales
TypeHardware Sales
Description

MicroPort Orthopedics generates revenue through the sale of hip and knee replacement implants and associated surgical instruments to hospitals, surgery centers, and surgeons. The company offers a comprehensive portfolio including primary and revision knee systems, acetabular hip systems, femoral stems, resurfacing systems, and tissue-sparing surgical approaches. Revenue is derived from direct hospital contracts and distributor arrangements across 70 countries.

microportortho.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1Anterior Path®
Description

Anterior, portal-assisted hip replacement approach utilizing a cannula for direct acetabulum access and in-line preparation.

microportortho.com
+11 more records
Core offering1 text field

MicroPort Orthopedics designs, manufactures, and commercializes hip and knee replacement implants and the associated surgical instrumentation used by orthopedic surgeons. The company focuses on clinically differentiated implant systems, including its signature medial-pivot knee platform, and supports minimally invasive approaches such as the SuperPATH hip technique. Products are marketed to hospitals, ambulatory surgery centers, and orthopedic specialty practices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 95% patient satisfaction with Medial-Pivot prosthesis
+5 more records
Product overview1 text field

MicroPort Orthopedics is a medical device company offering a comprehensive portfolio of hip and knee replacement solutions. The portfolio is organized around two core product lines: knee replacement systems centered on the Evolution and Advance medial-pivot knee designs (including primary, revision, and personalized solutions), and hip replacement systems featuring acetabular cups (Prime, Dynasty, Lineage, Procotyl, Exclusif), femoral stems (Profemur line), and resurfacing options (Conserve Plus). Supporting these are tissue-sparing surgical approaches (SuperPath, Anterior Path), advanced technology components (BioFoam cancellous titanium, A-Class and E-Class polyethylene bearings, NitrX coating), and the SkyWalker surgical robot. The company serves healthcare professionals in over 70 countries.

Product and service4 records
1Advance Medial-Pivot Knee System
CategoryKnee replacement implants
Description

A total knee replacement system featuring medial-pivot articulation designed to replicate natural knee motion for patients with end-stage knee arthritis. Intended for orthopedic surgeons performing primary total knee arthroplasty.

2Evolution Medial-Pivot Knee System
CategoryKnee replacement implants
Description

Next-generation medial-pivot total knee replacement platform building on the Advance design, intended for orthopedic surgeons seeking updated instrumentation and sizing options.

3SuperPATH Hip System
CategoryHip replacement implants and instrumentation
Description

A tissue-sparing hip replacement surgical technique and instrumentation set that enables total hip arthroplasty through a single incision, supporting faster recovery for patients. Used by orthopedic surgeons performing primary hip replacement.

4Profemur Hip Stem Portfolio
CategoryHip replacement implants
Description

Femoral stem implants for total hip replacement procedures, offered in multiple geometries to accommodate varying patient anatomy and surgical approaches.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-11-03
Description

MicroPort Orthopedics and Pixee Medical announced the commercialization of orthopedic surgery technology in the U.S., with the MicroPort Orthopedics Evolution Medial-Pivot Knee Implant integrated with the Pixee Medical Knee+ platform. The partnership was demonstrated at AAHKS 2022, combining MicroPort's implant technology with Pixee Medical's surgical navigation platform.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

CeramTec supplies BIOLOX®delta ceramic hip head components to MicroPort Orthopedics for use in their acetabular hip systems. BIOLOX®delta has 15 years of successful clinical experience with more than 8 million components sold globally. MicroPort Orthopedics distributes these ceramic components as part of their hip product portfolio.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

ATF manufactures the Liberty Hip System and Liberty ATF Dual Mobility System, which are distributed by MicroPort Orthopedics. The Liberty systems are compatible with select MicroPort Orthopedic hip heads. ATF also manufactures the Exclusif acetabular hip system distributed by MicroPort.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Advance® revision femoral component was designed in conjunction with the Hospital for Special Surgery (HSS), one of the leading orthopedic hospitals in the world. The HSS-designed spine and cam mechanism features in the Advance revision knee system and represents a co-development collaboration for revision knee implant design.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Developer of the TSolution One active robotic system for total knee arthroplasty. Most direct emerging competitor to MicroPort's SkyWalker robot in the orthopedic surgical robotics segment.

TypeDirect peer
Description

Largest pure-play orthopedic medtech competitor with Mako robotic-arm-assisted surgery platform and a broad hip/knee implant portfolio (Triathlon, Mako Total Knee). Directly comparable to MicroPort Orthopedics in primary joint reconstruction, surgical robotics, and hospital-channel GTM.

TypeDirect peer
Description

Global orthopedic player with Journey/Journey II knee systems, CORI handheld robotics, and a meaningful hip franchise. Directly comparable in primary joint reconstruction, surgical robotics, and the regulatory/clinical-evidence-based selling motion MicroPort Orthopedics uses.

TypeDirect peer
Description

J&J's orthopedic arm offering Attune knee, Pinnacle hip, and Velys robotic-assisted surgery. Largest single competitor in joint reconstruction by global share, serving the same orthopedic surgeon and hospital customer base as MicroPort Orthopedics.

TypeDirect peer
Description

Swiss orthopedic company with GMK Sphere knee, AMIStem hip, and NextAR portable augmented-reality surgical platform. Closely comparable mid-cap peer in joint reconstruction, surgical approach innovation, and global distributor-led commercialization.

TypeDirect peer
Description

Orthopedic solutions provider with hip and knee implant lines (Empowr 3D knee, AltiVate hip) plus rehabilitation and bracing. Comparable in joint reconstruction implants and surgeon/hospital GTM.

TypeDirect peer
Description

Specialist orthopedic implant company (Optetrak knee, Truliant hip, Equinoxe shoulder) acquired by TPG in 2018. Most directly comparable mid-sized peer in joint reconstruction with similar surgeon-focused GTM and implant-led product strategy.

TypeRegional player
Description

French orthopedic specialist focused on lower-limb arthroplasty (knee, hip, foot/ankle) with an ANATOMICAL/TORNIER-style product line. Comparable in joint reconstruction portfolio but primarily serves the French/European market rather than competing head-to-head in the US.

TypeEmerging player
Description

Personalized knee implant company whose iTotal patient-specific technology directly overlaps with MicroPort's Prophecy personalized knee solutions. Comparable in patient-matched instrumentation and personalized arthroplasty niche.

TypeDirect peer
Description

Top-tier hip and knee implant manufacturer (Persona, NexGen, Vanguard) competing head-to-head in primary/revision arthroplasty. Comparable across implants, ROSA robotics, and the surgeon/hospital channel that MicroPort Orthopedics serves.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MicroPort Orthopedics

Orthopedic Implantsmicroportortho.com

MicroPort Orthopedics is a privately held medical device subsidiary of MicroPort Scientific Corporation that designs, manufactures, and distributes hip and knee replacement implants, tissue-sparing surgical approaches, and an FDA-cleared surgical robot, serving orthopedic surgeons and hospitals across 70 countries.

What MicroPort Orthopedics does

MicroPort Orthopedics is a privately held medical device company specializing in hip and knee replacement implants and the surgical approaches used to implant them. The company is a subsidiary of MicroPort Scientific Corporation, a China-headquartered multinational medical device group, and operates its principal office in Arlington, Tennessee. It serves orthopedic surgeons, hospitals, and healthcare systems through a direct sales force in core markets and a distributor network that spans 70 countries across North America, Europe, and Asia. The product portfolio is organized around two pillars: knee reconstruction, anchored by the proprietary medial-pivot design introduced in 1998 (Advance) and continued through the Evolution system, including NitrX-coated and BioFoam cementless variants; and hip reconstruction, which includes five acetabular cup platforms (Prime, Dynasty, Lineage, Procotyl, Exclusif), the Profemur femoral stem line, the Conserve Plus resurfacing system, and the Liberty dual-mobility system. Supporting both pillars are tissue-sparing surgical approaches (SuperPath, Anterior Path, SuperCap, PATH) and the SkyWalker FDA-cleared surgical robot.

The company's core technology differentiation is rooted in the medial-pivot knee design, which uses a medial ball-in-socket articulation with lateral mobility to replicate natural knee kinematics, backed by over 1,000,000 implanted cases, 95% reported patient satisfaction, and 98.8% survivorship at 17 years. Material science differentiation comes from BioFoam cancellous titanium for biological fixation, A-Class and E-Class highly cross-linked polyethylene bearing surfaces (with 92% wear reduction versus conventional polyethylene), NitrX titanium niobium nitride coating to reduce metal ion release, and BIOLOXdelta ceramic bearings sourced from CeramTec. The company generates revenue primarily through hardware sales of implants and instruments to hospitals and surgery centers, with pricing negotiated through hospital procurement channels rather than publicly disclosed. Distribution combines direct enterprise field sales in core geographies with channel partner/distributor arrangements internationally. Notable strategic partnerships include a November 2022 US commercialization alliance with Pixee Medical for AR-based surgical navigation integrated with the Evolution knee, an OEM/licensing relationship with CeramTec for ceramic hip heads, distribution agreements with ATF for Liberty and Exclusif hip systems, and a co-development relationship with the Hospital for Special Surgery for the Advance revision knee component.

The company employs 501-1,000 people and raised approximately $81.8M in a May 2020 funding round led by China Life Healthcare Fund. Leadership includes President Benny Hagag, CTO/VP Global Marketing and R&D Paul Bryant, and senior commercial, operations, and applied research officers across its US headquarters and international offices.

MicroPort Orthopedics firmographics

Firmographics
Name
MicroPort Orthopedics
Legal name
MicroPort Orthopedics Inc.
Website
https://microportortho.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
501–1,000 employees
Short description
MicroPort Orthopedics is a privately held medical device subsidiary of MicroPort Scientific Corporation that designs, manufactures, and distributes hip and knee replacement implants, tissue-sparing surgical approaches, and an FDA-cleared surgical robot, serving orthopedic surgeons and hospitals across 70 countries.
Ownership category
akta.pro rank

MicroPort Orthopedics industry classification

Industry
Product category
Orthopedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

  • Orthopedic medical devices
  • Hip replacement implants
  • Knee replacement systems
  • Joint reconstruction
  • Minimally invasive surgery

Where MicroPort Orthopedics is headquartered

Location

Headquarters

HQ city
Arlington
HQ country
United States
HQ region
North America

Offices7 records

Markets served

MicroPort Orthopedics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others

Revenue model

  1. Hip and Knee Implant Sales: MicroPort Orthopedics generates revenue through the sale of hip and knee replacement implants and associated surgical instruments to hospitals, surgery centers, and surgeons. The company offers a comprehensive portfolio including primary and revision knee systems, acetabular hip systems, femoral stems, resurfacing systems, and tissue-sparing surgical approaches. Revenue is derived from direct hospital contracts and distributor arrangements across 70 countries.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

MicroPort Orthopedics product offering

Product offering

Core offering

MicroPort Orthopedics designs, manufactures, and commercializes hip and knee replacement implants and the associated surgical instrumentation used by orthopedic surgeons. The company focuses on clinically differentiated implant systems, including its signature medial-pivot knee platform, and supports minimally invasive approaches such as the SuperPATH hip technique. Products are marketed to hospitals, ambulatory surgery centers, and orthopedic specialty practices.

Product overview

MicroPort Orthopedics is a medical device company offering a comprehensive portfolio of hip and knee replacement solutions. The portfolio is organized around two core product lines: knee replacement systems centered on the Evolution and Advance medial-pivot knee designs (including primary, revision, and personalized solutions), and hip replacement systems featuring acetabular cups (Prime, Dynasty, Lineage, Procotyl, Exclusif), femoral stems (Profemur line), and resurfacing options (Conserve Plus). Supporting these are tissue-sparing surgical approaches (SuperPath, Anterior Path), advanced technology components (BioFoam cancellous titanium, A-Class and E-Class polyethylene bearings, NitrX coating), and the SkyWalker surgical robot. The company serves healthcare professionals in over 70 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Anterior Path®: Anterior, portal-assisted hip replacement approach utilizing a cannula for direct acetabulum access and in-line preparation.
  • SuperPath®
  • Evolution®
  • Advance®
  • Profemur®
  • Conserve® Plus
  • Dynasty®
  • Prime
  • Prophecy®
  • BioFoam®
  • Skywalker®
  • MPO Magna

Products and services

  • Advance Medial-Pivot Knee System A total knee replacement system featuring medial-pivot articulation designed to replicate natural knee motion for patients with end-stage knee arthritis. Intended for orthopedic surgeons performing primary total knee arthroplasty.
  • Evolution Medial-Pivot Knee System Next-generation medial-pivot total knee replacement platform building on the Advance design, intended for orthopedic surgeons seeking updated instrumentation and sizing options.
  • SuperPATH Hip System A tissue-sparing hip replacement surgical technique and instrumentation set that enables total hip arthroplasty through a single incision, supporting faster recovery for patients. Used by orthopedic surgeons performing primary hip replacement.
  • Profemur Hip Stem Portfolio Femoral stem implants for total hip replacement procedures, offered in multiple geometries to accommodate varying patient anatomy and surgical approaches.

Quantifiable outcome

  • 95% patient satisfaction with Medial-Pivot prosthesis
  • +5 more outcomes

Companies that use MicroPort Orthopedics

Customer profile

Segments1 record

Ideal customer profiles2 records

MicroPort Orthopedics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature9 records

MicroPort Orthopedics partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Pixee MedicalcoreTechnology or Integration · 3 November 2022MicroPort Orthopedics and Pixee Medical announced the commercialization of orthopedic surgery technology in the U.S., with the MicroPort Orthopedics Evolution Medial-Pivot Knee Implant integrated with the Pixee Medical Knee+ platform. The partnership was demonstrated at AAHKS 2022, combining MicroPort's implant technology with Pixee Medical's surgical navigation platform.
  • CeramTeccoreOEM/ Whitelabel/ Licensing PartnerCeramTec supplies BIOLOX®delta ceramic hip head components to MicroPort Orthopedics for use in their acetabular hip systems. BIOLOX®delta has 15 years of successful clinical experience with more than 8 million components sold globally. MicroPort Orthopedics distributes these ceramic components as part of their hip product portfolio.
  • ATF (Advanced Technology Finance)minorOEM/ Whitelabel/ Licensing PartnerATF manufactures the Liberty Hip System and Liberty ATF Dual Mobility System, which are distributed by MicroPort Orthopedics. The Liberty systems are compatible with select MicroPort Orthopedic hip heads. ATF also manufactures the Exclusif acetabular hip system distributed by MicroPort.
  • Hospital for Special Surgery (HSS)coreStrategic or Co-development PartnerThe Advance® revision femoral component was designed in conjunction with the Hospital for Special Surgery (HSS), one of the leading orthopedic hospitals in the world. The HSS-designed spine and cam mechanism features in the Advance revision knee system and represents a co-development collaboration for revision knee implant design.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

MicroPort Orthopedics competitors and assessment

Company assessment

Emerging players

  • THINK Surgical: Developer of the TSolution One active robotic system for total knee arthroplasty. Most direct emerging competitor to MicroPort's SkyWalker robot in the orthopedic surgical robotics segment.
  • ConforMIS / restor3d: Personalized knee implant company whose iTotal patient-specific technology directly overlaps with MicroPort's Prophecy personalized knee solutions. Comparable in patient-matched instrumentation and personalized arthroplasty niche.

Direct peers

  • Stryker Corporation: Largest pure-play orthopedic medtech competitor with Mako robotic-arm-assisted surgery platform and a broad hip/knee implant portfolio (Triathlon, Mako Total Knee). Directly comparable to MicroPort Orthopedics in primary joint reconstruction, surgical robotics, and hospital-channel GTM.
  • Smith+Nephew: Global orthopedic player with Journey/Journey II knee systems, CORI handheld robotics, and a meaningful hip franchise. Directly comparable in primary joint reconstruction, surgical robotics, and the regulatory/clinical-evidence-based selling motion MicroPort Orthopedics uses.
  • DePuy Synthes (Johnson & Johnson): J&J's orthopedic arm offering Attune knee, Pinnacle hip, and Velys robotic-assisted surgery. Largest single competitor in joint reconstruction by global share, serving the same orthopedic surgeon and hospital customer base as MicroPort Orthopedics.
  • Medacta International: Swiss orthopedic company with GMK Sphere knee, AMIStem hip, and NextAR portable augmented-reality surgical platform. Closely comparable mid-cap peer in joint reconstruction, surgical approach innovation, and global distributor-led commercialization.
  • DJO (Enovis): Orthopedic solutions provider with hip and knee implant lines (Empowr 3D knee, AltiVate hip) plus rehabilitation and bracing. Comparable in joint reconstruction implants and surgeon/hospital GTM.
  • Exactech (TPG): Specialist orthopedic implant company (Optetrak knee, Truliant hip, Equinoxe shoulder) acquired by TPG in 2018. Most directly comparable mid-sized peer in joint reconstruction with similar surgeon-focused GTM and implant-led product strategy.
  • Zimmer Biomet: Top-tier hip and knee implant manufacturer (Persona, NexGen, Vanguard) competing head-to-head in primary/revision arthroplasty. Comparable across implants, ROSA robotics, and the surgeon/hospital channel that MicroPort Orthopedics serves.

Regional players

  • Amplitude Surgical: French orthopedic specialist focused on lower-limb arthroplasty (knee, hip, foot/ankle) with an ANATOMICAL/TORNIER-style product line. Comparable in joint reconstruction portfolio but primarily serves the French/European market rather than competing head-to-head in the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MicroPort Orthopedics social profiles

Digital presence

MicroPort Orthopedics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MicroPort Orthopedics leadership team

Management profile

Number of profiles

Profiles1 record

MicroPort Orthopedics funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MicroPort Orthopedics M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroPort Orthopedics

What does MicroPort Orthopedics do?

MicroPort Orthopedics designs, manufactures, and commercializes hip and knee replacement implants and the associated surgical instrumentation used by orthopedic surgeons. The company focuses on clinically differentiated implant systems, including its signature medial-pivot knee platform, and supports minimally invasive approaches such as the SuperPATH hip technique. Products are marketed to hospitals, ambulatory surgery centers, and orthopedic specialty practices.

Is MicroPort Orthopedics a public or private company?

MicroPort Orthopedics is a private company. It is classified as corporate owned and is currently operating.

When was MicroPort Orthopedics founded?

MicroPort Orthopedics was founded in 1998. It employs 501 to 1,000 people.

Where is MicroPort Orthopedics based?

MicroPort Orthopedics is headquartered in Arlington, United States, in the North America region.

How does MicroPort Orthopedics make money?

One revenue line is on record: hip and Knee Implant Sales.

Who are MicroPort Orthopedics's main competitors?

Emerging players on record are THINK Surgical and ConforMIS / restor3d. Direct peers are Stryker Corporation, Smith+Nephew, DePuy Synthes (Johnson & Johnson), Medacta International, DJO (Enovis), Exactech (TPG) and Zimmer Biomet. Amplitude Surgical is listed as a regional player.

Does MicroPort Orthopedics have an API?

No public API is recorded for MicroPort Orthopedics.

What industry is MicroPort Orthopedics in?

MicroPort Orthopedics's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The TribuneChennai Surgeon Crosses 300 Evolution® Medial-Pivot Knee Replacements in Under a Year, Championing Personalised Knee ReplacementDr. Vetri Kumar, Senior Consultant Orthopaedic Surgeon at Parvathy Hospital in Chennai, has become the first surgeon in South Asia to complete more than 300 Total Knee Replacement procedures using the Evolution® Medial-Pivot Knee System in under a year. The milestone reflects growing adoption of personalised knee replacement approaches that prioritise restoring native knee kinematics over conventional mechanical alignment methods. MicroPort Orthopedics, the manufacturer of the Evolution® system, cited the achievement as evidence of how personalised arthroplasty can improve patient quality of life.openPR.comTrends in Growth, Segment Analysis, and Competitive Strategies Influencing the Tibial Bearings MarketThe tibial bearings market is projected to grow to $1.91 billion by 2030, with a compound annual growth rate of 8.2%, driven by advancements in medical technology, demand for customized knee implants, robotic-assisted surgeries, and material innovations. In August 2024, Samsung Medison Co., Ltd. completed the acquisition of France-based Sonio to expand its maternal and fetal health imaging portfolio, while MicroPort Orthopaedics launched its Evolution Tibial Cones across North America in September 2024. The report identifies key market players including Stryker Corporation, Zimmer Biomet Holdings Inc., and Smith & Nephew plc, and details segmentation by bearing system type, material, distribution channel, application, and end-user.BioSpectrum IndiaUS-based MicroPort Orthopedics launches implants and technology in IndiaUS-based MicroPort Orthopedics Inc. announced on April 14, 2025 the launch of its Evolution Medial-Pivot Knee implant system in India, designed for total knee replacement surgery with superior flexion stability and anatomic motion. The product has documented 98.8% survivorship at 17 years and 95% patient satisfaction, with over one million cases performed across 70 countries. The company trained Indian surgeons through its Joint Academy platform before the launch to provide access to this technology for Indian patients.PR NewswireMicroPort Orthopedics Releases Renowned Speaker Lineup for Second Annual Global Medial-Pivot SymposiumMicroPort Orthopedics announced its second annual Global Medial-Pivot Symposium, scheduled for October 13-14, 2023, in Phoenix, Arizona, featuring over 25 faculty members from leading institutions worldwide. The two-day educational event will celebrate the 25th anniversary of the Medial-Pivot knee design and cover topics including robotics, digital enabling technologies, personalized surgical approaches, and patient care pathways in total knee arthroplasty. The symposium aims to bring together orthopedic surgeons to explore innovations in medial-pivot knee technology and improve patient outcomes.PR NewswireMicroPort Orthopedics Announces Second Annual Global Medial-Pivot Symposium in Phoenix, Arizona from October 13-14MicroPort Orthopedics announced registration is open for its second annual Global Medial-Pivot Symposium, scheduled for October 13-14, 2023, in Phoenix, Arizona. The symposium will celebrate the 25-year clinical excellence anniversary of the company's Medial-Pivot Knee implant and feature world-renowned orthopedic surgeons presenting on design principles, scientific evidence, and alignment strategies for medially stabilizing total knee arthroplasty. The event aims to provide continuing education to surgeons on the medial-pivot knee design and its role in improving patient outcomes and long-term survivorship.PR NewswireMicroPort Orthopedics Expands Commercial Leadership Team with Global Vice President of Marketing and Professional Education and North America Vice President of SalesMicroPort Orthopedics announced two strategic hires to expand its commercial leadership team: Brian Collins as Global Vice President of Marketing and Professional Education, and Shawn Gabriel as Vice President of Sales for North America. Brian brings over 12 years of medical device experience including roles at ZimVie, Stryker, DePuy Synthes, and Zimmer Biomet, while Shawn has over 20 years of experience leading sales teams at companies including Johnson & Johnson, Smith & Nephew, and Medtronic. The company stated these additions are part of its strategy to advance its position as a leader in the medical device industry and drive strategic growth in the US and globally.PR NewswireMicroPort Orthopedics Announces First Annual Global Medial-Pivot Symposium Taking Place in Chicago, October 13-15MicroPort Orthopedics announced it will host its first annual Global Medial-Pivot Symposium in Chicago from October 13-15, 2022, focusing on the latest scientific findings and research on medial pivot designs in total knee arthroplasty. The company, a pioneer of the medial pivot philosophy, appointed orthopedic surgeons Lowry Barnes and Scott Banks as symposium co-chairs to facilitate sessions alongside key faculty. The event aims to bring together top orthopedic surgeons and medical device professionals to discuss advancements and innovations in knee replacement techniques.PR NewswireMicroPort Orthopedics Welcomes C. Lowry Barnes, M.D. to Leadership Team as Medical DirectorMicroPort Orthopedics has appointed Dr. C. Lowry Barnes, a prominent orthopedic surgeon and former President of the American Association of Hip and Knee Surgeons, as its new Medical Director. Dr. Barnes, who previously served as a design surgeon for MicroPort's predecessor company and helped develop the Evolution Knee system, will contribute to strategic decision-making, medical education, clinical research, and product development. The company stated that Dr. Barnes's appointment reflects its commitment to advancing its position in the orthopedic device industry.PR NewswireMicroPort Orthopedics and Medacta Agree to Settlement on Patent ClaimsMicroPort Orthopedics and Medacta USA have agreed to settle a lawsuit that accused Medacta of patent infringement and tortious interference with contract, resolving claims that also extended to MicroPort's former distributor Advanced Surgical Devices, Inc. The settlement was announced jointly by both parties on July 14, 2021, bringing an end to the legal dispute without disclosing terms. This resolution allows both companies to move forward without continued litigation costs or uncertainties surrounding the patent claims.PR NewswireThe World Market for Hip and Knee Implants, 2019 to 2023 - Improving Surgical Robotic Systems Techniques & Decline in Global ASPsResearchAndMarkets.com published a global market report on hip and knee implants projecting the hip implant market to reach US$6.66 billion by 2023, growing at a CAGR of 2.05% during 2019-2023. The report identifies growth drivers including rising disposable income, aging population, and longer life expectancy, while noting challenges such as regulatory risk and insufficient medical reimbursement. The competitive landscape section profiles leading market players including Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, Integra LifeSciences, and MicroPort.